Related Experiment Video
Updated: Dec 5, 2025

Evaluation of Caspase Activation to Assess Innate Immune Cell Death
Published on: January 20, 2023
P2Y2 Receptor Induces L. amazonensis Infection Control in a Mechanism Dependent on Caspase-1 Activation and IL-1β
Maria Luiza Thorstenberg1, Monique Daiane Andrade Martins1, Vanessa Figliuolo1
1Laboratório de Imunofisiologia, Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.
Abstract:
Leishmaniasis is a neglected tropical disease caused by an intracellular parasite of the genus Leishmania. Damage-associated molecular patterns (DAMPs) such as UTP and ATP are released from infected cells and, once in the extracellular medium, activate P2 purinergic receptors. P2Y2 and P2X7 receptors cooperate to control Leishmania amazonensis infection. NLRP3 inflammasome activation and IL-1β release resulting from P2X7 activation are important for outcomes of L. amazonensis infection. The cytokine IL-1β is required for the control of intracellular parasites. In the present study, we investigated the involvement of the P2Y2 receptor in the activation of NLRP3 inflammasome elements (caspase-1 and 11) and IL-1β secretion during L. amazonensis infection in peritoneal macrophages as well as in a murine model of cutaneous leishmaniasis. We found that 2-thio-UTP (a selective P2Y2 agonist) reduced parasite load in L. amazonensis-infected murine macrophages and in the footpads and lymph nodes of infected mice. The antiparasitic effects triggered by P2Y2 activation were not observed when cells were pretreated with a caspase-1 inhibitor (Z-YVAD-FMK) or in macrophages from caspase-1/11 knockout mice (CASP-1,11-/-). We also found that UTP treatment induced IL-1β secretion in wild-type (WT) infected macrophages but not in cells from CASP-1,11-/- mice, suggesting that caspase-1 activation by UTP triggers IL-1β secretion in L. amazonensis-infected macrophages. Infected cells pretreated with IL-1R antagonist did not show reduced parasitic load after UTP and ATP treatment. Our in vivo experiments also showed that intralesional UTP treatment reduced both parasite load (in the footpads and popliteal lymph nodes) and lesion size in wild-type (WT) and CASP-11-/- but not in CASP-1,11-/- mice. Taken together, our findings suggest that P2Y2R activation induces CASP-1 activation and IL-1β secretion during L. amazonensis infection. IL-1β/IL-1R signaling is crucial for P2Y2R-mediated protective immune response in an experimental model of cutaneous leishmaniasis.
Insights
Activation of the P2Y2 receptor helps control Leishmania amazonensis infection by triggering caspase-1 and IL-1β secretion. This pathway is crucial for the immune response against cutaneous leishmaniasis.
Area of Science:
- Immunology
- Parasitology
- Tropical Diseases
Background:
- Leishmaniasis is a neglected tropical disease caused by Leishmania parasites.
- Damage-associated molecular patterns (DAMPs) like UTP and ATP activate P2 purinergic receptors on host cells.
- P2Y2 and P2X7 receptors play a role in controlling Leishmania amazonensis infection, with P2X7 activation leading to NLRP3 inflammasome activation and IL-1β release.
Purpose of the Study:
- To investigate the role of the P2Y2 receptor in NLRP3 inflammasome activation, caspase-1/11 and IL-1β secretion.
- To determine the involvement of P2Y2 receptor signaling in controlling Leishmania amazonensis infection in macrophages and a murine model of cutaneous leishmaniasis.
Main Methods:
- Murine peritoneal macrophages and a murine model of cutaneous leishmaniasis were used.
- Experiments involved treatment with P2Y2 agonists (2-thio-UTP, UTP) and antagonists.
- Caspase-1/11 knockout mice (CASP-1,11-/-) and caspase-1 inhibitor (Z-YVAD-FMK) were utilized to assess the role of caspase-1.
- IL-1 receptor antagonist was used to block IL-1β signaling.
Main Results:
- P2Y2 receptor activation by 2-thio-UTP reduced Leishmania amazonensis parasite load in macrophages and in vivo.
- Antiparasitic effects were dependent on caspase-1 activity, as they were abolished in CASP-1,11-/- mice and when caspase-1 was inhibited.
- UTP treatment induced IL-1β secretion in wild-type macrophages but not in CASP-1,11-/- macrophages.
- In vivo, UTP treatment reduced parasite load and lesion size in wild-type mice but not in CASP-1,11-/- mice.
- Blocking IL-1R signaling abrogated the protective effects of P2Y2 activation.
Conclusions:
- P2Y2 receptor activation triggers caspase-1 activation and subsequent IL-1β secretion during Leishmania amazonensis infection.
- IL-1β/IL-1R signaling is essential for the protective immune response mediated by the P2Y2 receptor in experimental cutaneous leishmaniasis.

